BR9608120A - Composição farmacêutica e processo para a preparação da mesma - Google Patents

Composição farmacêutica e processo para a preparação da mesma

Info

Publication number
BR9608120A
BR9608120A BR9608120A BR9608120A BR9608120A BR 9608120 A BR9608120 A BR 9608120A BR 9608120 A BR9608120 A BR 9608120A BR 9608120 A BR9608120 A BR 9608120A BR 9608120 A BR9608120 A BR 9608120A
Authority
BR
Brazil
Prior art keywords
preparing
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BR9608120A
Other languages
English (en)
Inventor
Jorgen Ryhl Svensson
Tina Meinertz Andersen
Lars Nygaard
Helle Weibel
Thyge Borup Hjorth
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of BR9608120A publication Critical patent/BR9608120A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9608120A 1995-05-05 1996-04-29 Composição farmacêutica e processo para a preparação da mesma BR9608120A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK52395 1995-05-05
PCT/DK1996/000192 WO1996034606A1 (en) 1995-05-05 1996-04-29 Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation

Publications (1)

Publication Number Publication Date
BR9608120A true BR9608120A (pt) 1999-02-09

Family

ID=8094516

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608120A BR9608120A (pt) 1995-05-05 1996-04-29 Composição farmacêutica e processo para a preparação da mesma

Country Status (26)

Country Link
US (1) US5866590A (pt)
EP (1) EP0830132B1 (pt)
JP (1) JP3195360B2 (pt)
KR (1) KR100440354B1 (pt)
CN (1) CN1092959C (pt)
AR (1) AR003418A1 (pt)
AT (1) ATE211911T1 (pt)
AU (1) AU707508B2 (pt)
BR (1) BR9608120A (pt)
CA (1) CA2220019C (pt)
CZ (1) CZ292256B6 (pt)
DE (1) DE69618586T2 (pt)
DK (1) DK0830132T3 (pt)
EG (1) EG23781A (pt)
ES (1) ES2171669T3 (pt)
HU (1) HU223075B1 (pt)
IL (1) IL118142A (pt)
MX (1) MX9708394A (pt)
MY (1) MY115016A (pt)
NO (1) NO318599B1 (pt)
NZ (1) NZ307159A (pt)
PL (1) PL183678B1 (pt)
PT (1) PT830132E (pt)
UA (1) UA43402C2 (pt)
WO (1) WO1996034606A1 (pt)
ZA (1) ZA963478B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
DE69803670T2 (de) * 1997-08-01 2002-11-21 Elan Corp Plc Dublin Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
JP2001518503A (ja) * 1997-10-02 2001-10-16 ハー・ルンドベック・アクチエゼルスカベット ５−（２−エチル−２ｈ−テトラゾール−５−イル）−１−メチル−１，２，３，６−テトラヒドロピリジンの粒状調合物
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
AU2002325404B2 (en) * 1998-01-22 2006-02-02 Abbott Laboratories Extended Release Tiagabine Formulations with Reduced Side-effects
WO2001089523A1 (en) * 2000-05-26 2001-11-29 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
WO2006067605A1 (en) * 2004-12-23 2006-06-29 Ranbaxy Laboratories Limited Stable pharmaceutical compositions of tiagabine and processes for their preparation
CN102125693A (zh) * 2011-01-25 2011-07-20 福建科瑞药业有限公司 一种盐酸噻加宾药物组合物及其制备方法
SG11201407309XA (en) * 2012-05-08 2014-12-30 Cellix Bio Private Ltd Compositions and methods for the treatment of epilepsy
WO2017038612A1 (ja) * 2015-08-28 2017-03-09 日本化薬株式会社 ラパマイシン又はその誘導体を含有する医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US501090A (en) * 1893-07-11 gennert
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies

Also Published As

Publication number Publication date
CA2220019C (en) 2007-12-11
WO1996034606A1 (en) 1996-11-07
JP3195360B2 (ja) 2001-08-06
ES2171669T3 (es) 2002-09-16
NO975076L (no) 1997-11-04
CZ292256B6 (cs) 2003-08-13
IL118142A0 (en) 1996-09-12
DK0830132T3 (da) 2002-04-29
DE69618586D1 (de) 2002-02-21
CA2220019A1 (en) 1996-11-07
IL118142A (en) 1999-11-30
ATE211911T1 (de) 2002-02-15
NO318599B1 (no) 2005-04-18
JPH10505359A (ja) 1998-05-26
MY115016A (en) 2003-03-31
DE69618586T2 (de) 2002-09-05
ZA963478B (en) 1996-11-13
CZ338897A3 (cs) 1998-03-18
EP0830132B1 (en) 2002-01-16
UA43402C2 (uk) 2001-12-17
EG23781A (en) 2007-08-13
CN1092959C (zh) 2002-10-23
HUP9802741A3 (en) 1999-04-28
HU223075B1 (hu) 2004-03-01
CN1183721A (zh) 1998-06-03
NZ307159A (en) 1998-10-28
MX9708394A (es) 1998-02-28
NO975076D0 (no) 1997-11-04
EP0830132A1 (en) 1998-03-25
KR100440354B1 (ko) 2004-09-18
PL183678B1 (pl) 2002-06-28
PT830132E (pt) 2002-07-31
AU707508B2 (en) 1999-07-15
HUP9802741A2 (hu) 1999-03-29
PL323138A1 (en) 1998-03-16
US5866590A (en) 1999-02-02
AU5644196A (en) 1996-11-21
AR003418A1 (es) 1998-08-05

Similar Documents

Publication Publication Date Title
BR9707251A (pt) Compostos processo para a preparação dos mesmos e composições farmacêuticas
BR9610706A (pt) Composição aquosa de branqueamento dos dentes e processo para preparar a mesma
BR9612135A (pt) Taxóides processo para sua preparação e composiç o farmacêutica
BR9611986A (pt) Compostos processo para a preparação dos mesmos composição farmcéutica e utilização dos compostos
BR9605354A (pt) Composto composição farmacêutica processo para a produção do composto e uso
BR9609701A (pt) Composição farmacéutica composto e processo para a preparação de compostos
PT909327E (pt) Eritromicinas e processo para a sua preparacao
PT799866E (pt) Negro-de-fumo e processo para a sua preparacao
BR9611027A (pt) Unidade de estrutura e processo para fabrica-Æo da mesma
BR9707839A (pt) Primido-Ú5,4-D¾-primidas medicamentos contendo esses compostos sua aplicação e processo para a sua preparação
BR9600821A (pt) Composto formulação farmacêutica e processo para a preparação de um composto
BR9407306A (pt) Composição farmacêutica para a administação oral e processo para preparar a mesma
BR9408219A (pt) Comprimidos de paroxetina e um processo para a sua preparação
BR9606782A (pt) Processo para preparar ciclopilacetileno
BR9606396A (pt) Derivados de camptotecin substituídos e processo para sua preparação
BR9711340A (pt) Composto composi-Æo farmac-utica e processo para preparar um composto
BR9608120A (pt) Composição farmacêutica e processo para a preparação da mesma
BR9607095A (pt) Composto composição farmacêutica e processos para fabricar e para administrar um composto
BR9506106A (pt) Composto processo para sua preparação medicamento e composição farmacêutica
PT900253E (pt) Composicoes de betume e um processo para a sua preparacao
BR9402961A (pt) Forma de dosagem farmacêutica seca por congelamento e processo para preparação da mesma
BR9608374A (pt) Processo para a prepara-Æo de cloridrato de lercanidipina
BR9707811A (pt) Processo para preparação de um composto e composto
BR9407301A (pt) Escova rotativa e processo para a preparação da mesma
BR9601294A (pt) Composto e processo para preparação do mesmo

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AO REQUISITO DE ATIVIDADE INVENTIVA,COM BASE NO ARTIGO 8O C/C 13 DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]